Revenue has grown double digits four quarters running, billed business hit +9% in Q2 and ROE is 36% — yet AXP trades at ~18.5× trailing earnings, near its March low, because revenue guidance rose while EPS guidance held and expenses grew 12%. Four lenses became six, three scenarios, four horizons. Next catalyst: Q3 results on Oct 23.
Gray = dated closing anchors (Sep 26 ’25 to Oct 6 ’26; the Dec 12 high, Jan 12 and Mar 20 low are intraday; the window is 12 months because sourced daily history beyond that was unavailable). Colored paths = scenario midpoints, probabilities bear 30% · base 45% · bull 25% — tilted to the bear side because Q3 is 17 days away, expense growth is running ahead of revenue and the rate-cap overhang is unresolved. Street 12-month consensus ≈ $372 (range $329–$450). Non-zero price axis.
Those probabilities are a judgment call — make them yours. Drag the bear and bull weights (base takes the remainder); the blended target, the dotted line and the prob-weighted row of each scenario card update live.
Synthesized perspectives, each with its own 12-month target. Panel range $216–$383, mean $322 — below the $372 Street consensus.
Four straight double-digit revenue quarters, billed business +9% (best FX-adjusted pace in three years) and net card fees +15% for a 32nd double-digit quarter. Younger members are the fastest-growing cohort. A 36% ROE earns a premium multiple.
TTM free cash flow of $15.1B is a ~7.3% yield; $7.5B of TTM buybacks plus $2.4B of dividends retire 2.5% of shares a year. At 15× 2027E EPS the stock is the cheapest it has been in over a year while CET1 sits at 10.4%.
Card Member services cost is +50% and card adds slowed to 1.3M a quarter. Revenue guidance rose but EPS guidance did not, which says growth is being bought. A 10% rate-cap push and stablecoin or agentic bypass cap the multiple.
Amex is issuer, network and merchant acquirer at once, so it keeps the data and the merchant relationship. 76,800 employees run ~$456B a quarter of billed business, and the affluent base has kept delinquency near 1.2% for three years.
Price sits below the 50-day ($326) and 200-day ($332) averages with RSI near 36, 4.7% above the March low. Estimate cuts and target trims are clustering ahead of Q3, which is typical of an oversold base, not yet a reversal.
A K-shaped consumer favors Amex’s affluent base, but higher inflation, firmer gas prices and tighter Fed messaging pressure rate-sensitive financials. Regulatory risk (rate cap, interchange) is a standing discount.
Sorted low to high. Consensus ≈ $372 (+22%); the dashed line is today’s $304.55. Holds are clustered at $320–$345 after this week’s cuts.
Targets from firm notes dated Sep 23–Oct 6, 2026 (TipRanks/TheFly via StockAnalysis); *JPMorgan’s $400 Overweight dates from mid-July. Rating mix Sep ’26: 14 Buy/Strong Buy, 14 Hold, 0 Sell. Consensus conflict: $372.33 on the Oct 6 statistics page vs $377.91 on the Oct 5 forecast page; the later figure is used.
Scenario midpoints (mid-year) vs today’s $304.55, each = calendar-year EPS × exit multiple. Illustrative frameworks, not forecasts.
For a card issuer, debt funds the loan book rather than signaling leverage, so read free cash flow against capex.
*2026E: revenue and FCF are consensus estimates ($79.5B, $11.9B); capex ($3.4B) and total debt ($59.1B) are trailing to Jun 30, 2026. Revenue is company-basis net of interest expense ($60.5B/$65.9B/$72.2B); aggregator series run ~$5B lower. Capex has roughly doubled since 2023 ($1.6B to $3.4B TTM). TTM FCF is $15.1B, so the 2026E estimate looks conservative or reflects timing.
Each scenario price is an EPS estimate times an exit multiple. This is the ladder under the base case.
2024 ($13.35) is derived from FY25 $15.38 and its +15.2% growth; 2026E–2027E ($17.65, $20.16) are consensus (company guide $17.30–$17.90 for 2026); 2028E–2031E are this desk’s base extension of +13% fading to +10%. Base 2031E ≈ $31.2 × 17× ≈ $530.
Q2 FY26 year-over-year — read against a stock 21% below its high.
Every line is positive and net card fees (clay) lead. The cost mirror is Card Member services expense at +50%: that is the bear’s whole point, and the number Q3 must reconcile. Billed business is +9% FX-adjusted.
The valuation argument compresses into one disagreement: are the perks an investment or a giveaway?
The hot cell is likely and high-impact: costlier growth. Regulatory and macro risks sit one row down in “possible.”
Perk and acquisition spend grow faster than fees, so revenue beats keep failing to reach EPS.
A statutory cap on card APRs would cut net interest income of ~$24B a year.
A hit to affluent spend lifts write-offs from a 2.0% base and slows billed business.
Fewer new Platinum and Gold accounts weakens the fee flywheel.
Chase and Capital One premium cards pressure acquisition; normalized write-offs (~1.7% consumer) reset the credit story.
The pending GBT stake sale and co-brand portfolio sales move reported lines without changing the core.
Stablecoin or agentic-commerce rails reroute payments around closed-loop economics.
Hover the dotted terms in the metrics, or scan the working definitions.